---
schema_version: "secwatch.filing_event.v1"
accession: "0001570562-25-000074"
form_type: "8-K"
ticker: "EOLS"
cik: "0001570562"
company_name: "Evolus, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T08:03:27.981565+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Evolus Q1 revenue $68.5M (+15.5% YoY); reaffirms FY2025 guidance; Evolysse launch strong

## Summary
- Q1 global net revenue $68.5M, up 15.5% from Q1 2024 on higher volumes and market share gains.
- GAAP operating loss $15.2M; non-GAAP operating loss $5.5M (excludes stock-based comp, depreciation).
- Reaffirmed FY2025 revenue guidance $345M to $355M, representing 30-33% growth over 2024.
- Evolysse HA filler launched April 2025; strong early adoption; expected 8-10% of 2025 revenue.
- On track for positive non-GAAP operating income in Q4 2025 and full-year 2025; tariffs no impact.

## SEC filing metadata
- accession: 0001570562-25-000074
- form_type: 8-K
- ticker: EOLS
- cik: 0001570562
- company_name: Evolus, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1570562/000157056225000074/0001570562-25-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1570562/000157056225000074/eols-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001570562-25-000074
- JSON: https://secwatch.observer/filing/0001570562-25-000074.json
- Plain text: https://secwatch.observer/filing/0001570562-25-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.